Effect of a low-intensity PSA-based screening intervention on prostate cancer mortality: The CAP randomized clinical trial

Medicine and Dentistry

• Cancer Mortality 100%
• Prostate Specific Antigen 100%
• Prostate Cancer 100%
• Randomized Clinical Trial 100%
• Gleason Score 18%
• All Cause Mortality 18%
• Instrumental Variable Analysis 18%
• Cancer Staging 9%
• Neoplasm 9%
• Quality of Life 9%
• Primary Health Care 9%
• Prostate Specific Antigen Test 9%
• Cluster Randomized Trial 9%
• Cancer Screening 9%
• Prostate Biopsy 9%

Nursing and Health Professions

• All Cause Mortality 18%
• Instrumental Variable Analysis 18%
• Standard of Practice 9%

Keyphrases

• P 50 14%
• Screening Clinic 14%
• Rate Difference 14%